This article discusses the accuracy and complications of percutaneous biopsy of adrenal masses and the rapidly evolving new methods for noninvasive differential diagnosis using CT scan, MR imaging, and radio-nuclide scintigraphy. We offer our current recommendations for the evaluation of benign versus malignant adrenal masses and speculate on the optimal approach for the near future.